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Abstract: Osteoarthritis is characterized by lubrication failure of the articular cartilage and severe inflammation
of the joint capsule. Lubricating mesoporous silica nanoparticles (MSNs) have been developed for the treatment
of osteoarthritis based on enhanced lubrication and local drug delivery. However, MSNs are difficult to degrade
in vivo in a short time, resulting in potential toxic effect due to bioaccumulation. In this study, biodegradable
MSNs (bMSNs) were prepared through an oil–water biphase stratification method, and modified with
poly(2-methacryloyloxyethyl phosphocholine) (PMPC) to synthesize lubricating drug-loaded nanoparticles
(bMSNs–NH2@PMPC) by photopolymerization. The in vitro degradation test demonstrated that the bMSNs
and bMSNs–NH2@PMPC almost degraded within 7 days. The tribiological test showed that the lubrication
property of the bMSNs–NH2@PMPC was greatly improved, with a reduction of 50% in the friction coefficient
(COF) compared with the bMSNs. It was attributed to hydration lubrication mechanism by which a tenacious
hydration layer is formed surrounding the zwitterionic headgroups (N+(CH3)3 and PO4− ) in PMPC polyelectrolyte
polymer. Additionally, the bMSNs–NH2@PMPC maintained excellent lubrication property under degradation
and achieved sustained drug release behavior compared with the bMSNs. In summary, the biodegradable
bMSNs–NH2@PMPC developed in this study with the properties of enhanced lubrication and drug delivery
may be a promising approach for osteoarthritis therapy.
Keywords: biodegradable; mesoporous silica nanoparticles; lubrication; drug delivery; osteoarthritis
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Introduction

Osteoarthritis is a chronic joint disease characterized
by articular cartilage degeneration and inflammation
of joint capsule, which severely affects quality of life
for the patients [1, 2]. Currently, the clinical treatment
methods mainly include intra-articular injection of
viscosupplement (hyaluronic acid), oral administration
of chondroprotective agent (glucosamine), and surgical
replacement (joint arthroplasty) according to the
symptoms of osteoarthritis [3–5]. Although surgical
replacement can eliminate or alleviate joint pain

immediately, it may result in serious complications
by aggravating the burden of other organs, especially
when patients have symptomatic diseases, such as
high blood pressure, heart disease, and diabetes [6, 7].
Consequently, it is more preferrable to treat osteoarthritis
at an early stage. As the occurrence of osteoarthritis
is highly related with the significant increase in joint
friction and the stimulation in inflammatory response,
a therapy combining lubrication restoration and drug
intervention is considered effective as an innovative
strategy for the treatment of osteoarthritis [8, 9].
Recently, lubricating hollow silica nanoparticles
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and mesoporous silica nanoparticles (MSNs) have
been developed to treat osteoarthritis [10–12]. These
nanoparticles could not only greatly enhance lubrication
but also show chondroprotective potential through
encapsulating anti-inflammatory drugs into the
mesoporous channels. The synergistic effect of lubrication
enhancement and sustained drug release of the
nanoparticles has made a significant progress for the
treatment of early-stage osteoarthritis. However, the
serious long term bioaccumulation of the nanoparticles
is neglected in these studies. Since the “–Si–O–Si–”
skeleton structure is stable, the biodegradability of
MSNs is very slow in vivo, which may be extremely
aggregated in vital organs of human body, such as
liver, spleen, and bladder [13]. Subsequently, the long
term bioaccumulation of the nanoparticles would result
in serious problems such as inflammatory reaction,
oxidative damage, and organ fibrosis [14, 15]. The
concern of accumulation toxicity of the MSNs has greatly
hindered the progression to clinical transformation
[16, 17]. Therefore, it is considered necessary to develop
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biodegradable MSNs (bMSNs), which not only retain
the advantage of drug release performance but also
rapidly degrade and metabolize in organisms [18–22].
In the present study, bMSNs are prepared through
oil–water biphase stratification method. As shown in
Fig. 1(b), tetraethyl orthosilicate (TEOS) in the upper
oil phase continuously penetrates into the aqueous phase
and gradually hydrolyzes on the “Seed” surface,
eventually forming bMSNs with dendritic channels.
Compared with the dense MSNs prepared by rapid
condensing template method as shown in Fig. 1(a),
bMSNs have a loose “–Si–O–Si–” skeleton structure,
and thus biodegrade rapidly in vivo. Subsequently, the
bMSNs are grafted with poly(2-methacryloyloxyethyl
phosphocholine) (PMPC) to synthesize lubricating
drug-loaded nanoparticles (bMSNs–NH2@PMPC) by
photopolymerization. As indicated in Fig. 1(c), the
surface of bMSNs with hydroxyl group is modified
with amino group and photoinitiator (I2959-Tos), and
reacted with the MPC monomer to obtain bMSNs–
NH2@PMPC under UV–irradiation. It is hypothesized

Fig. 1 Schematic illustration showing the synthesis of nanoparticles: (a) MSNs by rapid condensing template method, (b) bMSNs by
oil–water biphase stratification method, and (c) bMSNs–NH2@PMPC by photopolymerization.
www.Springer.com/journal/40544 | Friction
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that the bMSNs–NH2@PMPC with the properties
of biodegradability, enhanced lubrication, and drug
delivery can be used as a promising agent in biomedical
applications, e.g., the treatment of osteoarthritis.

2 Materials and methods
2.1

Materials and reagents

2.4

2-methacryloyloxyethyl phosphocholine (MPC, 99%)
was purchased from Joy-Nature Corp., Nanjing,
China. Cetyltrimethylammonium chloride solution
(CTAC, 25 wt%), tetraethyl orthosilicate (TEOS, 98%),
cetyltrimethylammonium bromide (CTAB, 98%),
p-toluenesulfonyl chloride (TsCl, 99%), and (3aminopropyl) triethoxysilane (APTES, 98%) were
purchased from J&K Scientific Co., Beijing, China.
Rhodamine B (RhB, 98%), 2-hydroxy-4'-(2hydroxyethoxy)-2-methylpropiophenone (I2959, 96%),
and simulated body fluid (SBF) were purchased from
Solarbio Co., Beijing, China. Toluene, triethanolamine
(TEA), N,N-dimethylformamide (DMF), dichloromethane, methanol, cyclohexane, and other reagents
were obtained from Beijing Chemical Reagent Co.,
Beijing, China.
2.2

Synthesis of MSNs

0.14 g of NaOH, 0.5 g of CTAB, and 240 mL of
deionized water were stirred at 80 °C for 30 min.
Subsequently, 5 mL of TEOS was slowly added and
stirred for 6 h. The precipitate was gathered through
filtration, and washed thrice with deionized water
and methanol. Then, it was uniformly stirred in
an acidic methanol solution (containing 150 mL of
methanol and 1.5 mL of 10 mol/L HCl) at 60 °C for
12 h to remove the template. The final product (MSNs)
was filtered, washed sufficiently with methanol, and
dried overnight under vacuum [23].
2.3

environment in which the aqueous phase and the
organic phase were layered. The mixture was stirred
at a low speed (90 rpm) for 60 h. The bMSNs containing
the CTAC template in aqueous phase were collected
by centrifugation. Finally, it was uniformly dispersed
in the acidic methanol solution, and stirred at 60 °C
for 24 h to remove the template to obtain bMSNs.

Synthesis of bMSNs

The bMSNs were synthesized using a biphase
stratification method [24]. 120 mL of CTAC, 0.9 g of
TEA, and 180 mL of deionized water were continuously
stirred at 60 °C for 1 h. Subsequently, a mixed solution
(5 mL of TEOS and 95 mL of cyclohexane, 5 v/v%)
was gently added to the aqueous solution to form an

Synthesis of aminated bMSNs–NH2

Briefly, bMSNs (1 g), anhydrous toluene (100 mL),
and APTES (10 mL) were refluxed under nitrogen
atmosphere at 110 °C for 24 h. Afterwards, the mixture
was centrifuged at 8,000 rpm for 10 min. The product
was washed thrice with toluene and methanol, and dried
overnight under vacuum to obtain bMSNs–NH2.
2.5

Synthesis of bMSNs–NH2@PMPC

I2959 (2.69 g, 0.012 mol), TsCl (1.90 g, 0.010 mol), KOH
(2.24 g, 0.040 mol), and 30 mL of dichloromethane
were stirred at 25 °C for 2 h. Then, the mixture was
washed with deionized water, and the organic phase
was dried over Na2SO4 and distilled. Silica gel column
chromatography, with an elution of methylene
chloride and ethyl acetate (1:4, v/v), was employed to
purify the product (2959-Tos, photoinitiator). Subsequently, I2959-Tos (1 g), K2CO3 (2 g), bMSNs–NH2
(400 mg), and 10 mL of DMF were stirred at 120 °C
for 24 h under nitrogen atmosphere. The mixture was
centrifuged at 8,000 rpm for 10 min. The precipitate
was washed sufficiently with ethanol and deionized
water, and dried to obtain the product of bMSNs–
NH2@I2959.
Finally, bMSNs–NH2@I2959 (200 mg), MPC (1 g),
and 10 mL of deionized water were stirred at 90 °C,
and irradiated with ultraviolet light (5 mW/cm2) under
nitrogen atmosphere for 2 h. The precipitate was
collected by centrifugation at 8,000 rpm for 30 min,
washed sufficiently with deionized water, and finally
dried to obtain the product of bMSNs–NH2@PMPC.
2.6 Characterizations
Transmission electron microscopy (TEM) was conducted
using an H-7650B instrument (Hitachi, Japan) to
examine the morphology of the nanoparticles. Particle
size analyzer (Zetasizer Nano ZS, Malvern Instruments,
Malvern, UK) was employed to measure the hydro-
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dynamic diameter and zeta potential of the nanoparticles based on dynamic light scattering (DLS).
Nitrogen adsorption–desorption isotherm and pore size
distribution were implemented using a NOVA4000
equipment (Quantachrome, CA, USA) to obtain the
specific surface area and pore volume of the nanoparticles. Additionally, Fourier transform infrared
(FTIR) spectrum was recorded employing a Nexus 670
spectrometer (Thermo-Nicolet, Madison, WI, USA)
at a wavelength from 500 to 2,500 cm−1. Thermogravimetric analysis (TGA) was performed using a
Q5000IR instrument (TA Instruments, New Castle,
DE, USA) at a heating rate of 10 °C/min from 25 to
800 °C. Scanning electron microscopy (SEM, SU8220,
Hitachi, Japan) associated with energy dispersive
spectroscopy (EDS) was used to characterize the
surface morphology of the wear areas on the samples
in the tribological test.
2.7

In vitro biodegradation

An acidic SBF was used to test the biodegradation
characteristics of the nanoparticles including MSNs,
bMSNs, and bMSN–NH2@PMPC. Briefly, an equivalent
amount of the nanoparticles (7.0 mg) was placed in
20 mL of SBF (pH = 5.5) at 37 °C. Aliquots were taken
and replaced by equal amount of fresh SBF at regular
intervals of 1, 3, and 7 days. The extracted solution
was centrifuged at 8,000 rpm to collect the nanoparticles. The morphology of the biodegraded
nanoparticles was observed using the TEM.
2.8

Rheological test

The rheological performance of the bMSNs–NH2@PMPC
nanoparticles under different concentrations (2, 4, 6,
and 10 mg/mL) in aqueous suspensions was examined
using a Physica MCR301 rheometer (Anton Paar,
Austria), which was equipped with a cone-and-plate
module (diameter: 49.955 mm; cone angle: 0.988°).
The curves of viscosity versus shear rate (10–8,000 s−1)
was obtained by dropping 1 mL of aqueous suspension
on the plate under shearing mode.
2.9

Tribological test

The lubrication property of bMSNs and bMSNs–
NH2@PMPC nanoparticles in aqueous suspensions
(5 mg/mL) was tested using a UMT-3 universal
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materials tester (Bruker, Billerica, MA, USA) in reciprocating mode (amplitude: 4 mm). The upper and lower
friction tribopairs were polytetrafluoroethylene (PTFE)
sphere (diameter: 8 mm) and polished Ti6Al4V sheet.
The tribological test was performed at different loads
(1, 2, and 4 N) and frequencies (1, 3, and 5 Hz), each
for a duration of 15 min. The curve of friction coefficient
(COF) versus time was recorded for the test. The
apparent maximum contact pressure was calculated
based on Hertz equation for ball-on-flat configuration
[25, 26].
3
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where P is the contact pressure (MPa), F is the applied
load (1, 2, and 4 N), μ1 and μ2 are the Poisson’s ratio of
PTFE (0.3) and Ti6Al4V (0.3), E1 and E2 are the elastic
modulus of PTFE (0.5 GPa) and Ti6Al4V (110 GPa),
and R (4 mm) is the radius of the PTFE sphere.
Consequently, P was calculated to be 15.4 MPa (1 N),
19.3 MPa (2 N), and 24.4 MPa (4 N), respectively.
2.10

Lubrication property of biodegraded nanoparticles

The lubrication property of biodegraded nanoparticles in aqueous suspensions (bMSNs and bMSNs–
NH2@PMPC, 5 mg/mL) was investigated employing
the UMT-3 universal materials tester. The bMSNs and
bMSNs–NH2@PMPC were dispersed ultrasonically in
SBF (pH = 5.5) and cultivated in a shaker at 37 °C.
Aliquots were taken and replaced by equal amount
of fresh SBF at regular intervals of 1, 3, 5, and 7 days.
The aqueous suspension was tested under the following
experimental conditions: load: 2 N, frequency: 3 Hz.
The other test parameters were the same as above
mentioned.
2.11 In vitro drug loading and release
RhB was chosen as a model cargo to test the drug
loading and release characteristics of the nanoparticles.
Briefly, 20 mg of bMSNs and bMSNs–NH2@PMPC
was added to 10 mL of RhB solution (0.5 mM). After
stirring at room temperature for 2 h, the precipitate
was collected by centrifugation, washed with deionized
www.Springer.com/journal/40544 | Friction
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water, and dried under vacuum to obtain RhB-loaded
nanoparticles. The amount of RhB remaining in the
solution was calculated by measuring the absorbance
of the supernatant at 520 nm employing a UV–vis
spectrophotometer (UV-8000s, Metash Instruments,
Shanghai, China). The loading capacity (LC) and
encapsulation efficiency (EE) of the nanoparticles
were obtained by the following equations:
LC(%)bMSNs 

Amount of loaded RhB
 100
Amount of RhB  Loaded bMSNs
(2)

LC(%)bMSNs  NH2 @PMPC


Amount of loaded RhB
 100
A mount of RhB loaded bMSNs  NH 2 @PMPC

(3)
EE(%) 

Amount of loaded RhB
 100
Amount of added RhB

(4)

The drug release of the nanoparticles was tested by
the dialysis process. Briefly, 20 mg of drug-loaded
nanoparticles including MSNs, bMSNs, and bMSN–
NH2@PMPC were ultrasonically dispersed into 10 mL
of phosphate buffer solution (PBS). 2 mL of the
suspension was put into to a dialysis bag with a
molecular weight cutoff of 8,000–10,000, and dialyzed
in 18 mL of PBS at 37 °C. Subsequently, 2 mL of RhBcontaining dialysate was sucked out, and 2 mL of fresh
PBS was added at regular intervals. The absorbance
was measured by the spectrophotometer at 520 nm,
and the amount of RhB released from the nanoparticles
was calculated. After all the values at regular intervals
were obtained, the cumulative release–time curve of
RhB was plotted.
2.12 Statistical analysis
The data were presented as mean± standard deviation
(SD), and similar independent tests were repeated at
least three times to verify the results. The statistical
analysis was performed using GraphPad Prism software
(Version 5.0, GraphPad Software Inc., USA).

3

Results and discussion

3.1 Characterizations of nanoparticles
The morphologies of the MSNs, bMSNs, and bMSNs–

NH2@PMPC are observed by TEM. Figure 2(a) shows
that the average diameter of MSNs is approximately
100 nm, and the parallel channels were contained.
Figure 2(b) demonstrates that the average diameter of
bMSNs is roughly 240 nm, and internal pores present
a radial distribution. Figure 2(c) indicates that the
bMSNs–NH2@PMPC are covered by a polymer layer
with a thickness of ~25 nm. The pores of bMSN–
NH2@PMPC can be faintly seen due to the presence
of the PMPC polymer layer.
Nitrogen adsorption–desorption isotherms are
examined to analyze the mesopores of the nanoparticles.
As demonstrated in Fig. 2(d), all the isotherms of
MSNs, bMSNs, and bMSNs–NH2@PMPC show typical
type IV pattern, indicating a mesoporous structure.
The specific surface area and pore volume of the
nanoparticles were calculated, based on the Brunauer–
Emmett–Teller (BET) model, as 743.1 m2/g and
0.614 mL/g for MSNs, and 1,169.6 m2/g and 1.485 mL/g
for bMSNs. These values decrease significantly to be
179.89 m2/g and 0.568 mL/g for bMSNs–NH2@PMPC
after grafting of polyelectrolyte polymer on the nanoparticle surface. Pore size distribution of the three
nanoparticles, which is obtained by Barrett–Joyner–
Halenda (BJH) analysis, is shown in Fig. 2(e). It is
obvious that the pore size distribution of MSNs is
concentrated at 3 nm, while the pore size of bMSNs is
distributed from 3 to 12 nm, corresponding to the
mesopores from the central core to the outer surface
of the nanoparticles. However, the pore size of bMSNs–
NH2@PMPC is hardly shown due to the presence of
the polyelectrolyte polymer.
FTIR spectroscopy analysis of the nanoparticles is
shown in Fig. 2(f). The spectra of bMSNs, bMSNs–NH2,
bMSNs–NH2@I2959, and bMSNs–NH2@PMPC all
indicate the absorption band of Si–O–Si at 1,089 cm−1,
and only slight differences are noted in the spectrum
of bMSNs–NH2@I2959 compared with bMSNs–NH2.
The absorption band of C=O appears at 1,730 cm−1,
and the absorption bands of P–O and P=O in PO4−
appear at 966 and 1,242 cm−1, as demonstrated in the
spectrum of bMSNs–NH2@PMPC. The result indicates
that PMPC polyelectrolyte polymer has been
successfully grafted on the bMSNs surface via
photopolymerization.
TGA curves of the nanoparticles are presented
in Fig. 2(g), and the data are established with the
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Fig. 2 Characterizations of the nanoparticles. TEM images for (a) MSNs, (b) bMSNs, and (c) bMSNs–NH2@PMPC; (d) nitrogen
adsorption–desorption isotherms and (e) pore size distribution of MSNs, bMSNs, and bMSNs–NH2@PMPC; (f) FTIR spectra and (g)
TGA curves of bMSNs, bMSNs–NH2, bMSNs–NH2@I2959, and bMSNs–NH2@PMPC.

temperature starting from 100 °C to eliminate the
influence from bound water. It is obvious that the
weight loss of bMSNs, bMSNs–NH2, and bMSNs–
NH2@I2959 is 1.65%, 15.90%, and 21.63%, respectively.
Therefore, the content of the photoinitiator (I2959-Tos)
in bMSNs–NH2@I2959 is calculated to be ~6.81%. The
weight loss greatly increases to 37.01% for bMSNs–
NH2@PMPC, and consequently the content of the
PMPC polyelectrolyte polymer is calculated to be
~19.24%. The TGA result not only further confirms
the successful grafting of the PMPC polyelectrolyte
polymer on the nanoparticles surface, but also
specifically provides quantitative assessment for each
component of the nanoparticles.
The hydrodynamic diameter of the bMSNs, bMSNs–
NH2, and bMSNs–NH2@I2959 nanoparticles is 289.8,
297.5, and 280.8 nm, respectively, and there is no
significant difference among these nanoparticles.
However, the hydrodynamic diameter increases

remarkably to 590.3 nm for bMSNs–NH2@PMPC, which
is attributed to the hydration effect of the PMPC
polyelectrolyte polymer. The zeta potential of bMSNs,
bMSNs–NH2, bMSNs–NH2@I2959, and bMSNs–
NH2@PMPC is –15.8, 37.3, 20.3, and –5.94 mV, respectively. The values of zeta potential for bMSNs
and bMSNs–NH2@PMPC are negative because of the
presence of the hydroxyl groups and phosphate
groups in the nanoparticles, while the positive values
of zeta potential for bMSNs–NH2 and bMSNs–
NH2@I2959 are due to the presence of amino groups.
3.2

Biodegradation property

The biodegradation process of the nanoparticles
including MSNs, bMSNs, and bMSNs–NH2@PMPC is
demonstrated in Fig. 3. It is clearly shown from the
TEM images that the morphology of MSNs is not
changed from day 0 to day 7 (Fig. 3(a)), indicating that
almost no biodegradation has occurred. However, an
www.Springer.com/journal/40544 | Friction
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Fig. 3 TEM images showing the biodegradation behavior of the nanoparticles at various time points: (a) MSNs, (b) bMSNs, and (c)
bMSNs–NH2@PMPC.

obvious change has been observed for bMSNs
(Fig. 3(b)), as the diameter of the nanoparticles decreases
rapidly (i.e., 240, 190, and 140 nm at day 0, 1, and 3,
respectively), and only little remaining residue can be
detected at day 7. The same phenomenon is observed
for bMSNs–NH2@PMPC (Fig. 3(c)). The diameter of
bMSNs–NH2@PMPC decreases sharply from day 1 to
day 3, and only slight fragments are observed at day 7.
The faster biodegradation rate of bMSNs and
bMSNs–NH2@PMPC is attributed to the lower degree
of crosslinking of the silicate backbone and the higher
specific surface area. This is caused by the formation
of dendritic channels due to mild condensation of
the silicate at the oil–water interface in the biphase
stratification process [24]. In contrast, the rapid
condensing template method [23] for the synthesis of
MSNs results in highly crosslinked silicate framework,
which can greatly delay the biodegradation process.
As a consequence, the biodegradable nanoparticles
may be potentially applied in clinics because the
toxic effects due to the accumulation can be avoided.
3.3

Rheological property

The rheological property of the bMSNs–NH2@PMPC

aqueous suspension at different concentrations (2, 4,
6, and 10 mg/mL) depicted by viscosity versus shear
rate curve is shown in Fig. 4(a). Generally, viscosity
slightly increases with the increase in shear rate, and
it is consistent with the results of a previous study, in
which Liu et al. [10] report a shear-thickening behavior
of ploy(3-sulfopropyl methacrylate potassium salt)grafted hollow silica nanoparticles in aqueous
suspensions. Clinically, hyaluronic acid is used as the
viscosupplement to alleviate pain for the patient with
osteoarthritis through intra-articular injection to the
joint. However, hyaluronic acid has a shear-thinning
behavior, and the lubrication property is greatly
compromised under higher shear rate [27]. From this
viewpoint, the rheological behavior of the bMSNs–
NH2@PMPC, as the lubricant additive, is beneficial
for the treatment of osteoarthritis.
3.4

Lubrication property

The comparison of COF for the bMSNs and bMSNs–
NH2@PMPC aqueous suspensions (contact pressure:
19.3 MPa; frequency: 3 Hz; concentration: 5 mg/mL)
is displayed in Fig. 4(b), and the schematic diagram
of the tribological test is shown in Fig. 4(c). The COF
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Fig. 4 Rheological and lubrication properties of the nanoparticles: (a) viscosity–shear rate curves of bMSNs–NH2@PMPC at various
concentrations; (b) COF–time plots of bMSNs and bMSNs–NH2@PMPC; (c) schematic diagram of the tribological test setup; (d, e)
schematic illustration showing the hydration lubrication mechanism based on the formation of hydration layer surrounding the
phosphocholine headgroups in bMSNs–NH2@PMPC.

of bMSNs–NH2@PMPC is 0.088, which is much lower
than that of bMSNs (0.158). It is considered that the
reduction in COF is attributed to hydration lubrication
mechanism of the PMPC polyelectrolyte polymer
grafted on the surface of bMSNs nanoparticles [28].
The zwitterionic phosphocholine headgroups in PMPC
is the same as that of the phosphatidylcholine lipid in
articular cartilage, which lubricates the joint based on
the same mechanism [29, 30]. As demonstrated in
Figs. 4(d) and 4(e), the water molecules can form a
tenacious hydration layer around the zwitterionic
N+(CH3)3 and PO4− charges in the bMSNs–NH2@PMPC
due to the interaction between water dipole and
enclosed charges. The hydration layer can support
high pressure without deformation because of the
steric effect, and respond in a fluidlike manner under
shear with a high speed exchange between the water
molecules in the hydration layer and the nearby
“free” water molecules (typically the time scale in the
order of 10−9 s). Consequently, it results in a great
reduction in the interfacial friction of the contact
tribopair.
The surface morphology of the wear areas on
the Ti6Al4V sheet using the bMSNs and bMSNs–
NH2@PMPC aqueous suspensions as the lubricant is

shown in Fig. 5. With regard to bMSNs, the trace of
wear area is slightly visible and partly covered by
some irregular fragments (Fig. 5(a)). The elemental
distribution of the fragments corresponds to silicon,
as displayed in Fig. 5(b). This result indicates that the
bMSNs nanoparticles adsorb onto the Ti6Al4V sheet
during the tribological test, which may cause abrasive
wear of the tribopair. Likewise, a layer of bMSNs–
NH2@PMPC nanoparticles is also detected on the
Ti6Al4V sheet, and the trace of wear area on the Ti6Al4V
sheet is hardly observed, as shown in Figs. 5(c)
and 5(d). The presence of the bMSNs–NH2@PMPC
nanoparticles can effectively reduce wear generation
in the tribological test.
The comparison of lubrication properties of the
bMSNs and bMSNs–NH2@PMPC aqueous suspensions
under different experimental conditions are demonstrated in Fig. 6. Figures 6(a) and 6(b) present the
COF–time plots of bMSNs and bMSNs–NH2@PMPC
under various loads of 1, 2, and 4 N (frequency: 3 Hz).
The COF remains stable during the test, and the
average value is much lower for bMSNs–NH2@PMPC
(1 N: 0.107; 2 N: 0.089; 5 N: 0.082) than that of bMSNs
(1 N: 0.162; 2 N: 0.155; 5 N: 0.152). Figures 6(c) and
6(d) illustrate the COF–time plots of bMSNs and
www.Springer.com/journal/40544 | Friction
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Fig. 5 Surface morphology and elemental distribution of the wear areas using bMSNs and bMSNs–NH2@PMPC as the lubricant: (a, b)
bMSNs and (c, d) bMSNs–NH2@PMPC.

Fig. 6 Lubrication property of the nanoparticles under different
experimental conditions: COF–time plots of (a) bMSNs and (b)
bMSNs–NH2@PMPC under various loads of 1, 2, and 4 N;
COF–time plots of (c) bMSNs and (d) bMSNs–NH2@PMPC
under various frequencies of 1, 3, and 5 Hz.

bMSNs-NH2@PMPC under various frequencies of
1, 3, and 5 Hz (load: 2 N). Similarly, the average value
of COF for bMSNs–NH2@PMPC (1 Hz: 0.080; 3 Hz:
0.088; 5 Hz: 0.106) is much lower than that of bMSNs
(1 Hz: 0.124; 3 Hz: 0.155; 5 Hz: 0.186). As previously

mentioned, the load employed in the tribological test
corresponds equivalently to the maximum contact
pressure of 15.4 MPa (1 N), 19.3 MPa (2 N), and
24.4 MPa (4 N), respectively, which is larger than the
typical pressure at the human joint (~5 MPa) [31, 32].
The result of lubrication property of biodegraded
bMSNs and bMSNs–NH2@PMPC in aqueous suspensions is displayed in Figs. 7(a) and 7(b). Generally, the
COF values of the two nanoparticles decrease with
the biodegradation time from day 1 to day 7. With
regard to bMSNs, the COF shows a rapid decrease on
day 5 compared with that of day 3 (Fig. 7(a)), while it
is slightly changed for other time points. However,
the COF of bMSNs–NH2@PMPC presents a gradually
decreasing trend for all the tested time points. Combining with previous TEM images of the biodegraded
nanoparticles, it is indicated that the bMSNs–NH2@
PMPC keep an excellent lubrication property during
the biodegradation process.
3.5

In vitro drug release

The LC of the MSNs, bMSNs, and bMSNs–NH2@PMPC
nanoparticles is calculated to be 5.69%, 10.5%, and
1.22%, respectively. As expected, the value decreases
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to the hydration lubrication mechanism of the
zwitterionic phosphocholine headgroups in PMPC.
Importantly, the bMSNs–NH2@PMPC under biodegradation maintained stable lubrication performance.
Additionally, the drug release test indicated the
bMSNs–NH2@PMPC could release the pre-loaded
drug with a sustained behavior. Consequently, the
bMSNs–NH2@PMPC developed herein may be used
for biomedical applications to treat such diseases
where lubrication enhancement and drug intervention
are specifically required, i.e., early stage osteoarthritis.

Fig. 7 Lubrication property of the biodegraded nanoparticles for
(a) bMSNs and (b) bMSNs–NH2@PMPC; (c) calibration curve
of RhB with different concentrations; (d) drug release profiles of
the MSNs, bMSNs, and bMSNs–NH2@PMPC. Abs: absorbance.

greatly following grafting of PMPC polyelectrolyte
polymer on the bMSNs surface. Likewise, the EE of the
MSNs, bMSNs, and bMSNs–NH2@PMPC nanoparticles
is 47.3%, 91.6%, and 9.67%, respectively. The calibration
curve of the model drug RhB in PBS is shown in
Fig. 7(c), and the cumulative drug release profiles of the
RhB-loaded MSNs, bMSNs, and bMSNs–NH2@PMPC
are demonstrated in Fig. 7(d). At 72 h, 45.8% of RhB
is released from bMSNs–NH2@PMPC, which is much
lower than that from MSNs (78.1%) and bMSNs (86.3%).
It is considered that the PMPC polyelectrolyte polymer
grafted on the bMSNs surface results in sustained
drug release behavior of the bMSNs–NH2@PMPC.

4

Conclusions

In this study, bMSNs–NH2@PMPC with enhanced
lubrication and sustained drug release properties
were synthesized via photopolymerization. The nanoparticles were characterized by TEM, BET, FTIR, and
TGA to confirm the successful grafting of the PMPC
polyelectrolyte polymer on the bMSNs surface. The
biodegradation test demonstrated that the bMSNs–
NH2@PMPC almost degraded completely in SBF within
7 days, thus avoiding the potential toxic effect due
to accumulation in vivo. The lubrication test showed
improved lubrication property of the bMSNs–
NH2@PMPC (compared with the bMSNs) under
different experimental conditions. This was attributed
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